Shanghai Epimab Biotherapeutics Co., Ltd.

This early-stage trial tests a new drug called EMB-15 in about 50 adults with advanced solid tumors that have not responded to standard treatments. EMB-15 is a bi-specific antibody designed to help the immune system attack cancer cells. The main goals are to check safety, find th…

This study tests a new drug called EMB-01 in people with advanced colorectal cancer that has come back or spread. The goal is to see if different dosing schedules can shrink tumors and how safe the drug is. About 54 adults will take part, and they will be assigned to receive EMB-…